MicroRNA 3691 (MIR3691)

MicroRNA 3691 (MIR3691) is a member of the microRNA (miRNA) family, which are small, single-stranded, non-coding RNA molecules of about 21–23 nucleotides in length[3]. These molecules regulate gene expression post-transcriptionally by binding to complementary sequences in target messenger RNAs (mRNAs), leading to silencing through mRNA cleavage, destabilization, or inhibition of translation[3]. miRNAs, including MIR3691, are not considered classical therapeutic targets like receptors or enzymes but act as part of the RNA silencing complex to fine-tune gene expression in various biological processes[2][4]. While some miRNAs can be dysregulated in disease and have roles in cancer, inflammation, or other conditions, there is no established literature identifying MIR3691 itself as a conclusively validated therapeutic target, mechanism of drug action, or widely used disease biomarker. The use of circulating miRNAs as biomarkers is an active area of research, but MIR3691 does not have specific clinical utility currently assigned[3].

Other names

hsa-mir-3691mir-3691MIR3691

Not drug-targeted; endogenous mechanism involves base-pairing with target mRNAs to regulate stability and translation